| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ADGRV1 CUBN DYSF SCIN | 1.13e-09 | 749 | 92 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 2.56e-04 | 27 | 92 | 3 | GO:0004683 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHA9 DSCAM PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.88e-16 | 187 | 92 | 16 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHA9 DSCAM PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 6.02e-13 | 313 | 92 | 16 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DNAJA3 PCDHA9 DSCAM FGB PKP1 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 NCK1 PCDHA2 PCDHA1 FGG ADGRV1 NCK2 | 2.28e-10 | 1077 | 92 | 23 | GO:0098609 |
| GeneOntologyBiologicalProcess | response to calcium ion | 8.44e-05 | 161 | 92 | 6 | GO:0051592 | |
| GeneOntologyBiologicalProcess | cardiac left ventricle formation | 1.17e-04 | 4 | 92 | 2 | GO:0003218 | |
| GeneOntologyBiologicalProcess | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation | 1.17e-04 | 4 | 92 | 2 | GO:1903912 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 8.47e-07 | 5 | 93 | 3 | GO:0005954 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.66e-06 | 45 | 93 | 5 | GO:0033017 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 2.66e-06 | 88 | 93 | 6 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.19e-05 | 114 | 93 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | fibrinogen complex | 5.39e-04 | 8 | 93 | 2 | GO:0005577 | |
| GeneOntologyCellularComponent | junctional membrane complex | 6.91e-04 | 9 | 93 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 8.61e-04 | 10 | 93 | 2 | GO:0014701 | |
| MousePheno | aorta stenosis | 6.23e-05 | 17 | 65 | 3 | MP:0010463 | |
| MousePheno | decreased fetal size | 8.97e-05 | 229 | 65 | 7 | MP:0004200 | |
| MousePheno | abnormal fetal size | 1.11e-04 | 237 | 65 | 7 | MP:0004198 | |
| MousePheno | increased placenta intervillous maternal lacunae size | 1.27e-04 | 4 | 65 | 2 | MP:0011529 | |
| MousePheno | vascular stenosis | 1.30e-04 | 56 | 65 | 4 | MP:0005412 | |
| Domain | Cadherin_tail | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 5.29e-26 | 37 | 91 | 15 | PF15974 |
| Domain | Cadherin_CBD | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 5.29e-26 | 37 | 91 | 15 | IPR031904 |
| Domain | Cadherin_2 | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.05e-21 | 65 | 91 | 15 | PF08266 |
| Domain | Cadherin_N | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.05e-21 | 65 | 91 | 15 | IPR013164 |
| Domain | Cadherin_CS | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.35e-18 | 109 | 91 | 15 | IPR020894 |
| Domain | CADHERIN_1 | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.64e-18 | 113 | 91 | 15 | PS00232 |
| Domain | Cadherin | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.64e-18 | 113 | 91 | 15 | PF00028 |
| Domain | CADHERIN_2 | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.76e-18 | 114 | 91 | 15 | PS50268 |
| Domain | - | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.76e-18 | 114 | 91 | 15 | 2.60.40.60 |
| Domain | CA | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.00e-17 | 115 | 91 | 15 | SM00112 |
| Domain | Cadherin-like | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.15e-17 | 116 | 91 | 15 | IPR015919 |
| Domain | Cadherin | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.50e-17 | 118 | 91 | 15 | IPR002126 |
| Domain | CaMKII_AD | 4.46e-07 | 4 | 91 | 3 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 4.46e-07 | 4 | 91 | 3 | IPR013543 | |
| Domain | NCK | 2.35e-05 | 2 | 91 | 2 | IPR017304 | |
| Domain | - | 3.09e-05 | 13 | 91 | 3 | 3.10.450.50 | |
| Domain | NTF2-like_dom | 4.88e-05 | 15 | 91 | 3 | IPR032710 | |
| Domain | Cadherin_C | 5.12e-05 | 42 | 91 | 4 | IPR032455 | |
| Domain | Cadherin_C_2 | 5.12e-05 | 42 | 91 | 4 | PF16492 | |
| Domain | Fibrinogen_a/b/g_coil_dom | 7.02e-05 | 3 | 91 | 2 | IPR012290 | |
| Domain | Fib_alpha | 7.02e-05 | 3 | 91 | 2 | SM01212 | |
| Domain | Fib_alpha | 7.02e-05 | 3 | 91 | 2 | PF08702 | |
| Domain | Junctophilin | 1.40e-04 | 4 | 91 | 2 | IPR017191 | |
| Domain | DnaJ_C | 8.27e-04 | 9 | 91 | 2 | IPR002939 | |
| Domain | DnaJ_C | 8.27e-04 | 9 | 91 | 2 | PF01556 | |
| Domain | HSP40/DnaJ_pept-bd | 8.27e-04 | 9 | 91 | 2 | IPR008971 | |
| Domain | DAGK_acc | 1.03e-03 | 10 | 91 | 2 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 1.03e-03 | 10 | 91 | 2 | IPR000756 | |
| Domain | DAGKa | 1.03e-03 | 10 | 91 | 2 | SM00045 | |
| Domain | SH2 | 1.50e-03 | 101 | 91 | 4 | PF00017 | |
| Domain | SH2 | 2.05e-03 | 110 | 91 | 4 | SM00252 | |
| Domain | MORN | 2.06e-03 | 14 | 91 | 2 | SM00698 | |
| Domain | DAGKc | 2.06e-03 | 14 | 91 | 2 | SM00046 | |
| Domain | SH2 | 2.12e-03 | 111 | 91 | 4 | PS50001 | |
| Domain | SH2 | 2.19e-03 | 112 | 91 | 4 | IPR000980 | |
| Domain | - | 2.19e-03 | 112 | 91 | 4 | 3.30.505.10 | |
| Domain | MORN | 2.37e-03 | 15 | 91 | 2 | IPR003409 | |
| Domain | Diacylglycerol_kinase_cat_dom | 2.37e-03 | 15 | 91 | 2 | IPR001206 | |
| Domain | DAGK_cat | 2.37e-03 | 15 | 91 | 2 | PF00781 | |
| Domain | MORN | 2.37e-03 | 15 | 91 | 2 | PF02493 | |
| Domain | DAGK | 2.37e-03 | 15 | 91 | 2 | PS50146 | |
| Domain | NAD/diacylglycerol_kinase | 3.04e-03 | 17 | 91 | 2 | IPR016064 | |
| Domain | Fibrinogen_CS | 3.80e-03 | 19 | 91 | 2 | IPR020837 | |
| Domain | RCC1 | 4.21e-03 | 20 | 91 | 2 | PF00415 | |
| Domain | RCC1_1 | 4.64e-03 | 21 | 91 | 2 | PS00625 | |
| Domain | RCC1_2 | 4.64e-03 | 21 | 91 | 2 | PS00626 | |
| Domain | RCC1_3 | 4.64e-03 | 21 | 91 | 2 | PS50012 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 4.65e-03 | 69 | 91 | 3 | IPR020636 | |
| Domain | Reg_chr_condens | 5.09e-03 | 22 | 91 | 2 | IPR000408 | |
| Domain | - | 5.09e-03 | 22 | 91 | 2 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 5.56e-03 | 23 | 91 | 2 | IPR009091 | |
| Domain | Fibrinogen_a/b/g_C_2 | 6.04e-03 | 24 | 91 | 2 | IPR014715 | |
| Domain | - | 6.04e-03 | 24 | 91 | 2 | 4.10.530.10 | |
| Domain | DnaJ_domain_CS | 7.61e-03 | 27 | 91 | 2 | IPR018253 | |
| Domain | Fibrinogen_C | 7.61e-03 | 27 | 91 | 2 | PF00147 | |
| Domain | FBG | 8.75e-03 | 29 | 91 | 2 | SM00186 | |
| Domain | - | 9.35e-03 | 30 | 91 | 2 | 3.90.215.10 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 1.26e-06 | 45 | 60 | 5 | M27623 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 8.00e-06 | 65 | 60 | 5 | M38994 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 8.61e-06 | 10 | 60 | 3 | M26910 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 2.50e-05 | 82 | 60 | 5 | M27626 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.58e-05 | 14 | 60 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.58e-05 | 14 | 60 | 3 | M47388 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47385 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 3.33e-05 | 87 | 60 | 5 | M12467 | |
| Pathway | WP_ERBB_SIGNALING | 4.37e-05 | 92 | 60 | 5 | M39715 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 4.37e-05 | 92 | 60 | 5 | MM14951 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 4.78e-05 | 17 | 60 | 3 | M47387 | |
| Pathway | REACTOME_IRAK4_DEFICIENCY_TLR2_4 | 5.72e-05 | 18 | 60 | 3 | M27464 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 6.77e-05 | 19 | 60 | 3 | M47957 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 6.77e-05 | 19 | 60 | 3 | MM15473 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 6.83e-05 | 101 | 60 | 5 | M27253 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 7.94e-05 | 20 | 60 | 3 | M17670 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 9.23e-05 | 21 | 60 | 3 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 9.23e-05 | 21 | 60 | 3 | M27944 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.07e-04 | 22 | 60 | 3 | MM15104 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.22e-04 | 23 | 60 | 3 | MM14953 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.22e-04 | 23 | 60 | 3 | M47512 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 1.22e-04 | 23 | 60 | 3 | M27949 | |
| Pathway | WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART | 1.39e-04 | 24 | 60 | 3 | M39576 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.39e-04 | 24 | 60 | 3 | M47509 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.58e-04 | 25 | 60 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.58e-04 | 25 | 60 | 3 | M47511 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 2.08e-04 | 69 | 60 | 4 | M237 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 2.23e-04 | 28 | 60 | 3 | M837 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.23e-04 | 28 | 60 | 3 | M47508 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 2.48e-04 | 29 | 60 | 3 | MM15028 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 2.73e-04 | 74 | 60 | 4 | M48080 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 2.74e-04 | 30 | 60 | 3 | M257 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 2.96e-04 | 138 | 60 | 5 | MM15635 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 3.03e-04 | 31 | 60 | 3 | M7223 | |
| Pathway | REACTOME_DISEASES_OF_IMMUNE_SYSTEM | 3.33e-04 | 32 | 60 | 3 | M27428 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.33e-04 | 32 | 60 | 3 | M27455 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 3.33e-04 | 32 | 60 | 3 | M27900 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 3.65e-04 | 33 | 60 | 3 | M39875 | |
| Pathway | WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION | 3.69e-04 | 7 | 60 | 2 | M39868 | |
| Pathway | REACTOME_RAF_ACTIVATION | 3.99e-04 | 34 | 60 | 3 | M27556 | |
| Pathway | REACTOME_RAF_ACTIVATION | 4.35e-04 | 35 | 60 | 3 | MM15271 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 4.35e-04 | 35 | 60 | 3 | MM15109 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE | 4.91e-04 | 8 | 60 | 2 | M10546 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 5.14e-04 | 37 | 60 | 3 | M749 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 5.56e-04 | 38 | 60 | 3 | M27255 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 6.29e-04 | 9 | 60 | 2 | MM14966 | |
| Pathway | PID_IFNG_PATHWAY | 6.47e-04 | 40 | 60 | 3 | M161 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 6.80e-04 | 94 | 60 | 4 | M2843 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 6.96e-04 | 41 | 60 | 3 | M512 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 7.38e-04 | 464 | 60 | 8 | M27547 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_FIBRINOGEN_TO_FIBRIN | 7.84e-04 | 10 | 60 | 2 | M47879 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 8.57e-04 | 44 | 60 | 3 | M39845 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 8.57e-04 | 44 | 60 | 3 | M27934 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 1.04e-03 | 47 | 60 | 3 | M39531 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.04e-03 | 273 | 60 | 6 | M983 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 1.07e-03 | 106 | 60 | 4 | M518 | |
| Pathway | BIOCARTA_FIBRINOLYSIS_PATHWAY | 1.14e-03 | 12 | 60 | 2 | M2842 | |
| Pathway | BIOCARTA_FIBRINOLYSIS_PATHWAY | 1.14e-03 | 12 | 60 | 2 | MM1398 | |
| Pathway | BIOCARTA_EXTRINSIC_PATHWAY | 1.35e-03 | 13 | 60 | 2 | M4470 | |
| Pathway | BIOCARTA_EXTRINSIC_PATHWAY | 1.35e-03 | 13 | 60 | 2 | MM1395 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1 | 1.35e-03 | 13 | 60 | 2 | M6322 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.48e-03 | 53 | 60 | 3 | MM15716 | |
| Pathway | WP_VITAMIN_B12_METABOLISM | 1.56e-03 | 54 | 60 | 3 | M39337 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.56e-03 | 54 | 60 | 3 | M26911 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.56e-03 | 54 | 60 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.56e-03 | 54 | 60 | 3 | MM15202 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.64e-03 | 55 | 60 | 3 | M971 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.69e-03 | 203 | 60 | 5 | M5485 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.77e-03 | 205 | 60 | 5 | M752 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.81e-03 | 15 | 60 | 2 | M12101 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.81e-03 | 15 | 60 | 2 | M1262 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.81e-03 | 15 | 60 | 2 | MM14959 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.81e-03 | 15 | 60 | 2 | MM14965 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.81e-03 | 15 | 60 | 2 | MM14961 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.82e-03 | 57 | 60 | 3 | MM15643 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.26e-03 | 130 | 60 | 4 | M27454 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 2.26e-03 | 318 | 60 | 6 | MM15278 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 2.32e-03 | 131 | 60 | 4 | MM15717 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY | 2.33e-03 | 17 | 60 | 2 | M47728 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 2.43e-03 | 63 | 60 | 3 | M27862 | |
| Pathway | PID_BCR_5PATHWAY | 2.43e-03 | 63 | 60 | 3 | M10 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 2.60e-03 | 327 | 60 | 6 | M27565 | |
| Pathway | KEGG_GLIOMA | 2.65e-03 | 65 | 60 | 3 | M1835 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 2.95e-03 | 140 | 60 | 4 | M42572 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 3.22e-03 | 20 | 60 | 2 | M15394 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 3.27e-03 | 144 | 60 | 4 | MM14501 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 3.28e-03 | 70 | 60 | 3 | M3115 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY | 3.55e-03 | 21 | 60 | 2 | M47722 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 3.76e-03 | 472 | 60 | 7 | MM14539 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 3.90e-03 | 22 | 60 | 2 | M27571 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 3.90e-03 | 22 | 60 | 2 | MM15284 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 3.90e-03 | 22 | 60 | 2 | M39480 | |
| Pathway | REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 3.90e-03 | 22 | 60 | 2 | M17879 | |
| Pathway | REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 3.90e-03 | 22 | 60 | 2 | MM14558 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 3.98e-03 | 75 | 60 | 3 | M39568 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.26e-03 | 23 | 60 | 2 | M15997 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 4.26e-03 | 23 | 60 | 2 | MM15936 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.26e-03 | 23 | 60 | 2 | MM1427 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 4.26e-03 | 23 | 60 | 2 | M913 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | LIFR SETD1A HDAC6 CDK12 SUPT6H CAMK2B CAMK2D CAMK2G PSMA4 POLR2A PRKAB1 ZNF347 GATA4 | 4.86e-03 | 1387 | 60 | 13 | M734 |
| Pubmed | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.78e-40 | 15 | 93 | 15 | 15640798 | |
| Pubmed | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.05e-37 | 17 | 93 | 15 | 29911975 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 6.31e-37 | 18 | 93 | 15 | 15570159 |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 6.31e-37 | 18 | 93 | 15 | 10662547 |
| Pubmed | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.98e-34 | 24 | 93 | 15 | 24698270 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 5.39e-27 | 28 | 93 | 13 | 15347688 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.57e-26 | 57 | 93 | 15 | 32633719 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.11e-26 | 58 | 93 | 15 | 30377227 |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 | 1.24e-25 | 11 | 93 | 10 | 9655502 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.09e-25 | 68 | 93 | 15 | 11230163 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.97e-25 | 72 | 93 | 15 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.25e-24 | 74 | 93 | 15 | 10817752 |
| Pubmed | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.41e-24 | 77 | 93 | 15 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.50e-24 | 80 | 93 | 15 | 10716726 |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.59e-21 | 119 | 93 | 15 | 28625976 |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.65e-20 | 75 | 93 | 13 | 15372022 |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 9.42e-19 | 12 | 93 | 8 | 10612399 | |
| Pubmed | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.49e-18 | 193 | 93 | 15 | 22589738 | |
| Pubmed | PCDHA9 HDAC6 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA3 NCK1 PCDHA2 PCDHA1 DLX4 RIMS2 | 1.27e-14 | 329 | 93 | 15 | 17474147 | |
| Pubmed | 2.39e-10 | 5 | 93 | 4 | 34888534 | ||
| Pubmed | 5.97e-09 | 9 | 93 | 4 | 12154121 | ||
| Pubmed | Identification of novel human tumor cell-specific CaMK-II variants. | 1.85e-08 | 3 | 93 | 3 | 9060999 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 10819240 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 20844140 | ||
| Pubmed | Identification of two novel PCDHA9 mutations associated with Hirschsprung's disease. | 1.85e-08 | 3 | 93 | 3 | 29477871 | |
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 10381553 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 7.39e-08 | 4 | 93 | 3 | 17367784 | |
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 11889801 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 11013247 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 18218981 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 21209221 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 14722083 | ||
| Pubmed | Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. | 1.84e-07 | 5 | 93 | 3 | 16436603 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.10e-07 | 231 | 93 | 8 | 16452087 | |
| Pubmed | NEDD4 controls the expression of GUCD1, a protein upregulated in proliferating liver cells. | 3.68e-07 | 6 | 93 | 3 | 24743017 | |
| Pubmed | Multiple kinases regulate mafA expression in the pancreatic beta cell line MIN6. | 3.68e-07 | 6 | 93 | 3 | 18948074 | |
| Pubmed | Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. | 5.48e-07 | 59 | 93 | 5 | 23754746 | |
| Pubmed | Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II. | 6.43e-07 | 7 | 93 | 3 | 9115241 | |
| Pubmed | 1.03e-06 | 8 | 93 | 3 | 11264466 | ||
| Pubmed | 1.03e-06 | 8 | 93 | 3 | 20668654 | ||
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 12660151 | ||
| Pubmed | 2.19e-06 | 10 | 93 | 3 | 28361052 | ||
| Pubmed | 2.19e-06 | 10 | 93 | 3 | 19776387 | ||
| Pubmed | 3.01e-06 | 11 | 93 | 3 | 31045206 | ||
| Pubmed | 3.01e-06 | 11 | 93 | 3 | 17572674 | ||
| Pubmed | 4.00e-06 | 12 | 93 | 3 | 8615909 | ||
| Pubmed | 4.00e-06 | 12 | 93 | 3 | 8665664 | ||
| Pubmed | Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network. | 4.00e-06 | 12 | 93 | 3 | 21994455 | |
| Pubmed | 4.00e-06 | 12 | 93 | 3 | 12815021 | ||
| Pubmed | 6.60e-06 | 14 | 93 | 3 | 10373510 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15294044 | ||
| Pubmed | Identification and characterization of two splice variants of human diacylglycerol kinase eta. | 7.07e-06 | 2 | 93 | 2 | 12810723 | |
| Pubmed | Fine tuning of the threshold of T cell selection by the Nck adapters. | 7.07e-06 | 2 | 93 | 2 | 21078909 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 19242519 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 38597448 | ||
| Pubmed | Recent ultra-rare inherited variants implicate new autism candidate risk genes. | 7.07e-06 | 2 | 93 | 2 | 34312540 | |
| Pubmed | Fibrinogen C-terminal peptidic sequences (Haptides) modulate fibrin polymerization. | 7.07e-06 | 2 | 93 | 2 | 14691567 | |
| Pubmed | CaMK-II oligomerization potential determined using CFP/YFP FRET. | 7.07e-06 | 2 | 93 | 2 | 16185778 | |
| Pubmed | Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells. | 7.07e-06 | 2 | 93 | 2 | 9028318 | |
| Pubmed | Fibrinogen Tolaga Bay: a novel gammaAla341Val mutation causing hypofibrinogenaemia. | 7.07e-06 | 2 | 93 | 2 | 18000621 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 21880263 | ||
| Pubmed | Nck adaptor proteins modulate differentiation and effector function of T cells. | 7.07e-06 | 2 | 93 | 2 | 25995205 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 10490634 | ||
| Pubmed | Adipocyte CAMK2 deficiency improves obesity-associated glucose intolerance. | 7.07e-06 | 2 | 93 | 2 | 34303021 | |
| Pubmed | Nck adaptor proteins control the organization of neuronal circuits important for walking. | 7.07e-06 | 2 | 93 | 2 | 18093944 | |
| Pubmed | Nck adaptor proteins link Tks5 to invadopodia actin regulation and ECM degradation. | 7.07e-06 | 2 | 93 | 2 | 19596797 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 32610551 | ||
| Pubmed | Nck influences preosteoblastic/osteoblastic migration and bone mass. | 7.07e-06 | 2 | 93 | 2 | 26621720 | |
| Pubmed | Intron-less processed Pcdhalpha genes in the central nervous system. | 7.07e-06 | 2 | 93 | 2 | 14697259 | |
| Pubmed | PCDHA9 as a candidate gene for amyotrophic lateral sclerosis. | 7.07e-06 | 2 | 93 | 2 | 38467605 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 10693762 | ||
| Pubmed | Expression of CLLD7 and CHC1L Proteins in Oral Epithelial Dysplasia in a Group of Thai Patients. | 7.07e-06 | 2 | 93 | 2 | 38679985 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 6575689 | ||
| Pubmed | Nck adaptors are positive regulators of the size and sensitivity of the T-cell repertoire. | 7.07e-06 | 2 | 93 | 2 | 20709959 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 31619570 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 29992531 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 36035930 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 26567004 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 26006300 | ||
| Pubmed | A novel role for the fibrinogen Asn-Gly-Arg (NGR) motif in platelet function. | 7.07e-06 | 2 | 93 | 2 | 25413489 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 32239963 | ||
| Pubmed | Distinct Requirements for Adaptor Proteins NCK1 and NCK2 in Mammary Gland Development. | 7.07e-06 | 2 | 93 | 2 | 37479911 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 25124496 | ||
| Pubmed | The phosphotyrosine peptide binding specificity of Nck1 and Nck2 Src homology 2 domains. | 7.07e-06 | 2 | 93 | 2 | 16636066 | |
| Pubmed | Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition. | 7.07e-06 | 2 | 93 | 2 | 36068335 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 25193973 | ||
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 8.23e-06 | 15 | 93 | 3 | 14622581 | |
| Pubmed | 8.23e-06 | 15 | 93 | 3 | 9481670 | ||
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 1.47e-05 | 18 | 93 | 3 | 18311135 | |
| Pubmed | Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. | 1.74e-05 | 19 | 93 | 3 | 14578343 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 22988298 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 32126779 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 15217804 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 12706644 | ||
| Pubmed | Regulation of gamma-fibrinogen chain expression by heterogeneous nuclear ribonucleoprotein A1. | 2.12e-05 | 3 | 93 | 2 | 15671034 | |
| Pubmed | Nck-1 antagonizes the endoplasmic reticulum stress-induced inhibition of translation. | 2.12e-05 | 3 | 93 | 2 | 14676213 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 10891348 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 16144795 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 37906135 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 23061815 | ||
| Interaction | PCDHA10 interactions | PCDHA9 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 5.47e-26 | 22 | 90 | 13 | int:PCDHA10 |
| Interaction | PCDHA8 interactions | PCDHAC2 PCDHA13 PCDHA12 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.64e-16 | 55 | 90 | 11 | int:PCDHA8 |
| Interaction | PCDHA11 interactions | 8.35e-15 | 19 | 90 | 8 | int:PCDHA11 | |
| Interaction | FLT3 interactions | DNAJA3 PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 NCK1 PCDHA2 PCDHA1 | 5.03e-14 | 318 | 90 | 17 | int:FLT3 |
| Interaction | PCDHA7 interactions | 9.34e-14 | 14 | 90 | 7 | int:PCDHA7 | |
| Interaction | PCDHA9 interactions | 8.59e-11 | 32 | 90 | 7 | int:PCDHA9 | |
| Interaction | PCDHA3 interactions | 1.36e-10 | 34 | 90 | 7 | int:PCDHA3 | |
| Interaction | PCDHGA10 interactions | 1.73e-10 | 19 | 90 | 6 | int:PCDHGA10 | |
| Interaction | PCDHA1 interactions | 1.97e-10 | 9 | 90 | 5 | int:PCDHA1 | |
| Interaction | PCDHA4 interactions | 2.44e-10 | 60 | 90 | 8 | int:PCDHA4 | |
| Interaction | PCDHA6 interactions | 4.61e-08 | 9 | 90 | 4 | int:PCDHA6 | |
| Interaction | PCDHA12 interactions | 5.44e-08 | 46 | 90 | 6 | int:PCDHA12 | |
| Interaction | LONP2 interactions | 3.37e-07 | 62 | 90 | 6 | int:LONP2 | |
| Interaction | PCDHA2 interactions | 3.60e-07 | 14 | 90 | 4 | int:PCDHA2 | |
| Interaction | CIBAR2 interactions | 2.98e-06 | 7 | 90 | 3 | int:CIBAR2 | |
| Interaction | PCDHA13 interactions | 2.98e-06 | 7 | 90 | 3 | int:PCDHA13 | |
| Interaction | MAP10 interactions | 8.11e-06 | 29 | 90 | 4 | int:MAP10 | |
| Interaction | MLYCD interactions | 9.33e-06 | 30 | 90 | 4 | int:MLYCD | |
| Interaction | CAMK2N1 interactions | 1.01e-05 | 10 | 90 | 3 | int:CAMK2N1 | |
| Interaction | SHISA6 interactions | 4.02e-05 | 43 | 90 | 4 | int:SHISA6 | |
| Interaction | PCDHAC2 interactions | 4.82e-05 | 45 | 90 | 4 | int:PCDHAC2 | |
| Interaction | SH2D1A interactions | 4.82e-05 | 45 | 90 | 4 | int:SH2D1A | |
| Interaction | BLNK interactions | 6.23e-05 | 48 | 90 | 4 | int:BLNK | |
| Interaction | FAM163B interactions | 6.69e-05 | 18 | 90 | 3 | int:FAM163B | |
| Interaction | RCBTB1 interactions | 1.08e-04 | 21 | 90 | 3 | int:RCBTB1 | |
| Interaction | PCDHA5 interactions | 1.18e-04 | 4 | 90 | 2 | int:PCDHA5 | |
| Interaction | CBLN3 interactions | 1.18e-04 | 4 | 90 | 2 | int:CBLN3 | |
| Interaction | HP interactions | 1.40e-04 | 111 | 90 | 5 | int:HP | |
| Interaction | SLC9A5 interactions | 1.43e-04 | 23 | 90 | 3 | int:SLC9A5 | |
| Interaction | DYSF interactions | 1.70e-04 | 62 | 90 | 4 | int:DYSF | |
| Interaction | DGKD interactions | 1.84e-04 | 25 | 90 | 3 | int:DGKD | |
| Interaction | TTC5 interactions | 2.04e-04 | 65 | 90 | 4 | int:TTC5 | |
| Interaction | RELN interactions | 2.33e-04 | 27 | 90 | 3 | int:RELN | |
| Interaction | PIK3AP1 interactions | 2.33e-04 | 27 | 90 | 3 | int:PIK3AP1 | |
| Interaction | DDR1 interactions | 2.93e-04 | 130 | 90 | 5 | int:DDR1 | |
| Interaction | PDE4A interactions | 3.20e-04 | 30 | 90 | 3 | int:PDE4A | |
| Cytoband | 5q31 | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.47e-23 | 115 | 93 | 15 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 5.33e-17 | 298 | 93 | 15 | chr5q31 |
| Cytoband | 4q28 | 1.45e-04 | 9 | 93 | 2 | 4q28 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q14 | 1.57e-03 | 244 | 93 | 4 | chr13q14 | |
| GeneFamily | Clustered protocadherins | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.44e-23 | 64 | 69 | 15 | 20 |
| GeneFamily | SH2 domain containing | 6.00e-04 | 101 | 69 | 4 | 741 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 6.33e-04 | 10 | 69 | 2 | 1178 | |
| GeneFamily | Fibrinogen C domain containing | 4.07e-03 | 25 | 69 | 2 | 554 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 ABHD16B FAM178B PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PTGIR | 4.84e-17 | 261 | 93 | 17 | MM1277 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 ABHD16B FAM178B PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PTGIR | 2.63e-16 | 238 | 93 | 16 | M2020 |
| Coexpression | MIKKELSEN_IPS_WITH_HCP_H3K27ME3 | 1.84e-06 | 103 | 93 | 6 | M1967 | |
| Coexpression | MIKKELSEN_IPS_WITH_HCP_H3K27ME3 | 2.17e-06 | 106 | 93 | 6 | MM1265 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | 7.14e-06 | 199 | 93 | 7 | M4526 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 7.38e-06 | 200 | 93 | 7 | M7444 | |
| Coexpression | MIKKELSEN_ES_HCP_WITH_H3K27ME3 | 1.36e-05 | 41 | 93 | 4 | M2000 | |
| Coexpression | MIKKELSEN_ES_HCP_WITH_H3K27ME3 | 1.50e-05 | 42 | 93 | 4 | MM1275 | |
| Coexpression | MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED | 2.05e-05 | 93 | 93 | 5 | MM1266 | |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN | 7.40e-05 | 197 | 93 | 6 | M8133 | |
| Coexpression | GSE42724_MEMORY_VS_B1_BCELL_UP | 8.04e-05 | 200 | 93 | 6 | M9794 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP | 8.04e-05 | 200 | 93 | 6 | M3840 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-07 | 186 | 93 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.52e-07 | 132 | 93 | 6 | 6480feb3e4e898d610615ce14f598f419c623e07 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.05e-06 | 159 | 93 | 6 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-06 | 163 | 93 | 6 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 169 | 93 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | (4)_B_cells-(4)_B_mantle|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.37e-06 | 183 | 93 | 6 | 21b7fb6482eb1d5d31a4029e47e0992e8ddc8e2c | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.65e-05 | 167 | 93 | 5 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.91e-05 | 84 | 93 | 4 | 9417fffe0ba79f5851920258dcd0f6c09218be13 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.05e-05 | 85 | 93 | 4 | 642755ed2b562dd5e599a04a2b9730e8d29aefe8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.05e-05 | 85 | 93 | 4 | 2429bacccd103e5b2414264b4aff3103ed9d7cec | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 173 | 93 | 5 | afa6bb19df52541d8d17cbfac9cbdd18a5f3632d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-05 | 177 | 93 | 5 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-05 | 185 | 93 | 5 | 808d5e880069aff8866cd2c733b9fe568a37701f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.32e-05 | 185 | 93 | 5 | eb78614c4acf8d2ce7874d7e51e16997b76127ef | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.43e-05 | 186 | 93 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.43e-05 | 186 | 93 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.54e-05 | 187 | 93 | 5 | 6c43669e19b5b54d72d1f5d876184fee53c05f0b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.66e-05 | 188 | 93 | 5 | e239bcdbd210a398a5850cb6fbf171d402f45a4f | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.78e-05 | 189 | 93 | 5 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 5.02e-05 | 191 | 93 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-05 | 193 | 93 | 5 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-05 | 193 | 93 | 5 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-05 | 193 | 93 | 5 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.28e-05 | 193 | 93 | 5 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.41e-05 | 194 | 93 | 5 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.68e-05 | 196 | 93 | 5 | 4deaadb9796b907b7480fb7af5ed76ebad240850 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Neuronal-Subcortical|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.68e-05 | 196 | 93 | 5 | bf8fe28193348342987d361c8e8b9e1d6d542678 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.68e-05 | 196 | 93 | 5 | 9a6e4eea19348a6e3379d3b872456ab6280cb74f | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.82e-05 | 197 | 93 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.96e-05 | 198 | 93 | 5 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.96e-05 | 198 | 93 | 5 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.96e-05 | 198 | 93 | 5 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX-Bronchial_vessel|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.96e-05 | 198 | 93 | 5 | dcf334d13e5b0018fee24febccfef91c9e17843b | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.99e-05 | 101 | 93 | 4 | 86acaa2502f61baa714ae988b73e3e73a71e897e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 93 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.25e-05 | 200 | 93 | 5 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.25e-05 | 200 | 93 | 5 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 93 | 5 | eac33be484dc443794e66e473f03e98406c2983e | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.25e-05 | 200 | 93 | 5 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.25e-05 | 200 | 93 | 5 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.25e-05 | 200 | 93 | 5 | 4b1ae9f71f0fe998b06fa580885572d1fc1544e2 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.35e-05 | 110 | 93 | 4 | 5496c92932195386025254b9129d69b12c8e3340 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.35e-05 | 110 | 93 | 4 | 41306a2d4a5a39569437eb123e47f98ef8afab24 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.35e-05 | 110 | 93 | 4 | 1fe08060248b25329f73b80d74435c108bee1359 | |
| Drug | Azacitidine | GABRB1 PCDHA9 SCAMP4 GATA4 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.16e-10 | 415 | 92 | 15 | ctd:D001374 |
| Drug | dimethyl sulfide | 9.12e-08 | 55 | 92 | 6 | CID000001068 | |
| Drug | Niflumic acid [4394-00-7]; Down 200; 14.2uM; HL60; HT_HG-U133A | 1.47e-06 | 199 | 92 | 8 | 2399_DN | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.47e-06 | 199 | 92 | 8 | 3345_DN | |
| Disease | 1,5 anhydroglucitol measurement | PCDHA9 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.56e-28 | 29 | 90 | 14 | EFO_0008009 |
| Disease | visceral adipose tissue measurement, body mass index | PCDHA9 PCDHAC2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.19e-22 | 87 | 90 | 15 | EFO_0004340, EFO_0004765 |
| Disease | neutrophil count, basophil count | PCDHA9 RCBTB1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.62e-15 | 224 | 90 | 14 | EFO_0004833, EFO_0005090 |
| Disease | Abnormality of refraction | PCDHA9 DSCAM CDK12 RCBTB1 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 NEDD4 | 1.83e-12 | 673 | 90 | 18 | HP_0000539 |
| Disease | vital capacity | FLI1 PCDHA9 LLGL2 CDK12 CAMK2B CAMK2G CDADC1 JPH2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.05e-10 | 1236 | 90 | 21 | EFO_0004312 |
| Disease | post-traumatic stress disorder symptom measurement | 1.62e-10 | 82 | 90 | 8 | EFO_0008535 | |
| Disease | neuroticism measurement, cognitive function measurement | PCDHA9 DSCAM COP1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.78e-10 | 566 | 90 | 15 | EFO_0007660, EFO_0008354 |
| Disease | pulse pressure measurement | PCDHA9 DSCAM SUPT6H JPH2 PCDHAC1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 DYSF AHDC1 LACTB | 5.64e-09 | 1392 | 90 | 20 | EFO_0005763 |
| Disease | post-traumatic stress disorder | CLEC18B PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.21e-08 | 202 | 90 | 9 | EFO_0001358 |
| Disease | neutrophil count | PCDHA9 DSCAM RCBTB1 PRKAB1 FGB PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 DGKH NCK1 PCDHA2 PCDHA1 | 2.93e-08 | 1382 | 90 | 19 | EFO_0004833 |
| Disease | pulmonary embolism (biomarker_via_orthology) | 5.92e-06 | 12 | 90 | 3 | DOID:9477 (biomarker_via_orthology) | |
| Disease | Hereditary factor I deficiency disease | 2.75e-05 | 3 | 90 | 2 | cv:C0019250 | |
| Disease | DYSFIBRINOGENEMIA, CONGENITAL | 2.75e-05 | 3 | 90 | 2 | 616004 | |
| Disease | Familial dysfibrinogenemia | 2.75e-05 | 3 | 90 | 2 | cv:C0272350 | |
| Disease | Congenital afibrinogenemia | 2.75e-05 | 3 | 90 | 2 | cv:C2584774 | |
| Disease | AFIBRINOGENEMIA, CONGENITAL | 2.75e-05 | 3 | 90 | 2 | 202400 | |
| Disease | congenital afibrinogenemia (is_implicated_in) | 2.75e-05 | 3 | 90 | 2 | DOID:2236 (is_implicated_in) | |
| Disease | Dysfibrinogenemia, Congenital | 2.75e-05 | 3 | 90 | 2 | C0272350 | |
| Disease | Afibrinogenemia | 5.50e-05 | 4 | 90 | 2 | C0001733 | |
| Disease | Congenital hypofibrinogenemia | 5.50e-05 | 4 | 90 | 2 | C2584774 | |
| Disease | response to venlafaxine | 6.01e-05 | 25 | 90 | 3 | EFO_0006328 | |
| Disease | Fibrinogen Deficiency | 9.15e-05 | 5 | 90 | 2 | C4316812 | |
| Disease | Hypoplastic Left Heart Syndrome | 9.15e-05 | 5 | 90 | 2 | C0152101 | |
| Disease | heart conduction disease (implicated_via_orthology) | 1.28e-04 | 32 | 90 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | polycystic ovary syndrome | 8.28e-04 | 60 | 90 | 3 | EFO_0000660 | |
| Disease | serum non-albumin protein measurement | 8.45e-04 | 361 | 90 | 6 | EFO_0004568 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 9.41e-04 | 15 | 90 | 2 | EFO_0004791, HP_0002140 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 1.07e-03 | 16 | 90 | 2 | EFO_0004792, HP_0002140 | |
| Disease | factor XI measurement, Ischemic stroke | 1.21e-03 | 17 | 90 | 2 | EFO_0004694, HP_0002140 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.23e-03 | 152 | 90 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Self-injurious behavior | 1.77e-03 | 78 | 90 | 3 | HP_0100716 | |
| Disease | depressive symptom measurement | 1.96e-03 | 426 | 90 | 6 | EFO_0007006 | |
| Disease | Albuminuria | 2.43e-03 | 24 | 90 | 2 | C0001925 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQVSTYFLAAWTGPG | 6 | Q75L30 | |
| GFSGSSQTKKQPWYN | 336 | Q8NHY2 | |
| GLHWGGPTQSSAYGK | 1456 | Q9NYV4 | |
| NKNAPSTAGLGYGSW | 381 | Q06187 | |
| WSAGPANTQGAYGTG | 11 | O43823 | |
| GSFGAVNVYWKASPD | 3946 | Q8WXG9 | |
| SLLPNGGSGNSYWTG | 286 | P21854 | |
| GGSGNSYWTGLSSNK | 291 | P21854 | |
| VSKFTWQLNPSGAYG | 466 | Q9BWV3 | |
| QFAGASQWPFRQGYG | 1101 | Q5TGY3 | |
| GTLPTSGYGNSFGAW | 211 | Q92988 | |
| WFTYRKNFPAIGGTG | 51 | Q9Y4P1 | |
| GKSIGQWYGPNTVAQ | 136 | Q9Y4P1 | |
| GYSVLGWNHPGFGSS | 196 | Q9H3Z7 | |
| AWGANTYGQLGTGNK | 256 | Q8NDN9 | |
| WGYNNSGQVGSGSTV | 176 | O95199 | |
| WGANSYGQLGTGNKS | 281 | O95199 | |
| GVNSNSWTFKYGPGN | 861 | Q9Y5H5 | |
| QGTEGPGAVSWASAY | 1086 | Q9H0B3 | |
| VGAGVNSNSWTFKYG | 856 | Q9Y5H9 | |
| GVNSNSWTFKYGPGN | 861 | Q9UN73 | |
| KGGNVNQPSYAGWTA | 511 | Q8N7Z5 | |
| GAGVNSNSWTFKYGP | 846 | Q9UN72 | |
| PVGAGVNSNSWTFKY | 856 | Q9Y5I1 | |
| VNSNSWTFKYGPGNP | 861 | Q9Y5I1 | |
| GVNSNSWTFKYGPGN | 861 | Q9Y5H6 | |
| GVNSNSWTFKYGPGN | 861 | Q9Y5H8 | |
| GPKGQGEYSGSWNFG | 31 | Q9BR39 | |
| NAGTYGYWPSSVSGG | 476 | Q86Y46 | |
| PSLWAGTNGGTIYAF | 731 | Q6P1M3 | |
| YGSNGPQSFTVEQWG | 1261 | P46934 | |
| GSYNGQVGWFPSNYV | 146 | P16333 | |
| GSYNGQIGWFPSNYV | 151 | O43639 | |
| GYVSGWGQSDNFKLT | 221 | P00739 | |
| NSYKWAGGGFLSTVG | 391 | P83111 | |
| QTRPSGGKWTFSYIG | 111 | Q9NRM6 | |
| WDPYKQGFGNVATNT | 296 | P02675 | |
| GSQKYGAVWTGDNTA | 576 | Q8TET4 | |
| IGTPYQFNGSGSGKW | 426 | O95259 | |
| FYWNGGEGAVTGVNK | 191 | P18505 | |
| NWNGGSTGYADSVKG | 71 | A0A0C4DH32 | |
| AGVNSNSWTFKYGPG | 846 | Q9Y5H7 | |
| PSYAGGTNFWGGTKE | 851 | Q86XP1 | |
| GGYNNSKHRWPTGDN | 101 | Q14671 | |
| GVNSNSWTFKYGPGN | 861 | Q9Y5I3 | |
| GVNSNSWTFKYGPGN | 861 | Q9Y5I0 | |
| VGAGVNSNSWTFKYG | 856 | Q9Y5I2 | |
| AFWGTGKGYFNNNIP | 146 | Q7Z3B4 | |
| VGAGVNSNSWTFKYG | 871 | Q9H158 | |
| GAGVNSNSWTFKYGP | 916 | Q9Y5I4 | |
| TKSGAWFYNSGSNTP | 176 | Q9UQ26 | |
| GAGVNSNSWTFKYGP | 856 | Q9UN74 | |
| GGGFYATWNTQTLGC | 2791 | O60494 | |
| SKASTPNGYDNGIIW | 381 | P02679 | |
| GGAPDQYWNSTGFLA | 231 | Q9BTY2 | |
| SPGWSQAGADGAAYT | 86 | P43694 | |
| GTYHTSKGNPGSTWL | 181 | Q6ZMU1 | |
| YGFKTNWSPAGENVF | 646 | Q99715 | |
| TSFGYKNKVPAGGWF | 156 | Q9HB03 | |
| FGAASQYWTSPTGGI | 416 | Q01543 | |
| WSFQEGVQLPGSYSG | 206 | Q9NP62 | |
| KGNLVGGWQYSTFSG | 181 | Q9NTU7 | |
| NYPKAWQGASSGEAA | 256 | Q8TBE0 | |
| LNIPSYAGGTNFWGG | 841 | Q16760 | |
| GSQTPWTTGYVFHGK | 81 | P59910 | |
| GNLLGGWKYSSFSGF | 186 | Q6UW01 | |
| NWSTTGFGQGQGYTI | 291 | Q9UBN7 | |
| ASGSQHSYWKGGPTV | 166 | Q96EY1 | |
| YRGAGGSFQKAQTEW | 176 | Q969E2 | |
| VGNWGTTGLTYPKFS | 891 | O75923 | |
| QLYQSDPSGNYGGWK | 146 | P25789 | |
| GEQQAWFGFAGTPGY | 166 | Q13555 | |
| GDQQAWFGFAGTPGY | 166 | Q13557 | |
| DSPKSNGGGWSFTNF | 1076 | P42702 | |
| AGVNSNSWTFKYGPG | 851 | Q9UN75 | |
| KFQAGNGSWGYPIYN | 91 | Q13835 | |
| WYKFTLTAQNGVGPG | 1446 | O60469 | |
| QTFPLGLGDGQFYSW | 46 | Q49A17 | |
| SNLWPGAYAFSNGKK | 626 | Q5TD94 | |
| ATKGNFPATAWGGTG | 166 | Q14D33 | |
| GDQQAWFGFAGTPGY | 166 | Q13554 | |
| TGQQGYENSGPGFWT | 251 | Q96BY9 | |
| PQNSGYIWVGKGASQ | 546 | Q9Y6U3 | |
| APEFSWGGSGSYFNN | 186 | Q8IXR5 | |
| TGDYAPLGFWAQNGS | 31 | O60292 | |
| GGDGQKAPSFQWRNY | 6 | O15047 | |
| GGGKEVYLSGSFNNW | 86 | Q9Y478 | |
| QTFLGPTGVYTWNGL | 121 | Q8NCR9 | |
| PTGVYTWNGLGASFV | 126 | Q8NCR9 | |
| AYSPGGNWEVNGKTI | 181 | Q6UXF7 | |
| PAQWASSQYGYGGSG | 1581 | Q7KZ85 | |
| TKSYGATTQANGGWP | 541 | Q9P2U8 | |
| ENTYGNNFFKGGFWG | 536 | Q9H2G4 | |
| WAQPGGAAFSLAYAG | 176 | P43119 | |
| NQGATPAYGAWSPSV | 1521 | P24928 | |
| GGPSSWGYVSQALLF | 496 | Q9BXP2 | |
| GVNGPSDWQKYTSAF | 161 | O75841 | |
| GQKANNWGSPYKSNG | 251 | Q96SE7 | |
| TGPKGQGEYTGSWSH | 31 | Q8WXH2 | |
| PSGNTYQGTWAQGKR | 56 | Q8WXH2 | |
| AGNGAKYEGTWSNGL | 101 | Q8WXH2 |